MAM
Leo Burnett, Delhi, wins Aerens Gold Souk account
NEW DELHI: Leo Burnett Delhi has announced that it has bagged the Aerens Gold Souk account.
An official release informs that the agency won the account in a competitive multi-agency pitch. The other agencies in the fray were O&M, Lowe, Contract, Capital, Percept and Mudra. This is Leo Burnett Delhi’s fifth new business win in the last four months, following the acquisition of Atlas Cycles, National Geographic Channel, Zee News and a project on energy sharing across South Asia.
Aerens Gold Souk president GS Pillai said, “We chose Leo Burnett Delhi over the other agencies for several reasons. Our decision was based on Leo Burnett’s understanding and grasp of the concept of the souk, the way they developed the strategic direction, and finally the sincerity, commitment and interest shown by each member of the Leo Burnett team.”
Leo Burnett Delhi’s vice president Ali Imran added, “We are very excited about being given the opportunity to work with Aerens Gold Souk. The gold souk is a revolutionary concept and will definitely be a landmark in Indian retail. It is both a privilege and a challenge to be a part of the brand-building process, and we are looking forward to working with the client and making it a success.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
